Quest Diagnostics
DGX · NYSE · Diagnostics and Testing · Founded 1967
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Current Price
$252.92
Market Cap
$27.1B
Return Since Last Split
+36%
Last Split
Jun 21, 2005
Total Splits
2
Cumulative Multiple
4×
What If You Bought DGX Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$101,168
400 shares · 4×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jun 21, 2005 | $53.65 | 2-for-1 | 2× | 4× |
| Jun 1, 2001 | $30.90 | 2-for-1 | 2× | 2× |
Quest Diagnostics Market Cap Timeline
Validated annual market-cap history is available from 1997. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Quest Diagnostics's latest record in the split calendar is a 2-for-1 forward split effective 2005-06-21.